PI3Kγ-dependent macrophage reprogramming overcomes microenvironmental tumor protection in sunitinib-challenged renal cancer
Abstract In sunitinib-treated renal cancer, tumor-associated macrophages (TAMs) can support tumor survival while suppressing antitumor immunity, but whether both effects can be reversed simultaneously is unclear. We identify phosphoinositide 3-kinase γ (PI3Kγ) as a macrophage-associated target and develop a protease-responsive, macrophage-directed nanocarrier (IMNMP) delivering the PI3Kγ inhibitor eganelisib (IPI-549). Sunitinib-conditioned renal cancer cells induced a tumor-supportive macrophage state with increased PI3Kγ and enhanced tumor cell protection. Genetic PI3Kγ silencing or IMNMP attenuated this protection, promoted macrophage costimulatory/inflammatory programs and enhanced CD8⁺ T-cell responses. In vivo, IMNMP plus sunitinib improved tumor control and produced an immunostimulatory microenvironment with increased macrophage costimulation and CD8⁺ T-cell infiltration. Bulk and single-cell transcriptomics linked treatment to antigen-presentation, interferon-response and effector immune programs in tumor-associated myeloid cells. Together, PI3Kγ-dependent macrophage function is an actionable component of sunitinib-treated renal cancer, and macrophage-directed PI3Kγ inhibition may simultaneously reduce microenvironmental tumor protection and strengthen antitumor immunity.
Authors
- Jingang Jian
- He Wang (ORCID: https://orcid.org/0000-0002-5707-4559)
- Jianquan Hou (ORCID: https://orcid.org/0000-0002-3987-8166)
- Yufeng Hou (ORCID: https://orcid.org/0000-0003-2105-5409)
- Yuhua Huang (ORCID: https://orcid.org/0000-0002-0341-0078)
- Hongbo Xu (ORCID: https://orcid.org/0000-0002-0258-7840)
- Zhangxin He (ORCID: https://orcid.org/0009-0001-4459-1995)
- Anguo Zhao
- Xiaorui Hou
- Di Jiao
- Hao Jiang
- Xuedong Wei
- Xin Ye
- Xin Chen
Institutions
- First Affiliated Hospital of Soochow University (CN)
- The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital) (CN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-13
- DOI
- https://doi.org/10.21203/rs.3.rs-11707079/v1
- Primary Topic
- Immune cells in cancer
- Type
- preprint